News
Biomarkers predict efficacy of DKN-01 in endometrial cancer
High levels of DKK1 expression and the presence of Wnt or PIK3CA activating mutations are associated with better outcomes.
News
Gynecologic cancer patients at risk of insurance loss, ‘catastrophic’ costs
The Affordable Care Act did not spare many gynecologic cancer patients from financial hardship.
News
Rucaparib extends PFS in BRCA-mutated ovarian cancer, with an exception
The PARP inhibitor was superior to chemotherapy, except in patients with BRCA reversion mutations.
